Plasticizers and Cardiovascular Health: Role of Adipose Tissue Dysfunction
Open Access
- 25 February 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11
Abstract
Since the 1950s, the production of plastics has increased 200-fold, reaching 360 million tonnes in 2019. Plasticizers, additives that modify the flexibility and rigidity of the product, are ingested as they migrate into food and beverages. Human exposure is continuous and widespread; between 75 and 97% of urine samples contain detectable levels of bisphenols and phthalates, the most common plasticizers. Concern over the toxicity of plasticizers arose in the late 1990s, largely focused around adverse developmental and reproductive effects. More recently, many studies have demonstrated that exposure to plasticizers increases the risk for obesity, type 2 diabetes, and cardiovascular disease (CVD). In the 2000s, many governments including Canada, the United States and European countries restricted the use of certain plasticizers in products targeted towards infants and children. Resultant consumer pressure motivated manufacturers to substitute plasticizers with analogues, which have been marketed as safe. However, data on the effects of these new substitutes are limited and data available to-date suggest that many exhibit similar properties to the chemicals they replaced. The adverse effects of plasticizers have largely been attributed to their endocrine disrupting properties, which modulate hormone signaling. Adipose tissue has been well-documented to be a target of the disrupting effects of both bisphenols and phthalates. Since adipose tissue function is a key determinant of cardiovascular health, adverse effects of plasticizers on adipocyte signaling and function may underlie their link to cardiovascular disease. Herein, we discuss the current evidence linking bisphenols and phthalates to obesity and CVD and consider how documented impacts of these plasticizers on adipocyte function may contribute to the development of CVD.Keywords
This publication has 111 references indexed in Scilit:
- Exposure to bisphenol A induces dysfunction of insulin secretion and apoptosis through the damage of mitochondria in rat insulinoma (INS-1) cellsCell Death & Disease, 2013
- The endocrine disruptor mono-(2-ethylhexyl)phthalate promotes adipocyte differentiation and induces obesity in miceBioscience Reports, 2012
- Effects of Di(2-ethylhexyl) Phthalate (DEHP) on Female Fertility and Adipogenesis in C3H/N MiceEnvironmental Health Perspectives, 2012
- Resistin: functional roles and therapeutic considerations for cardiovascular diseaseBritish Journal of Pharmacology, 2012
- Perinatal Exposure to Bisphenol A Alters Early Adipogenesis in the RatEnvironmental Health Perspectives, 2009
- Polycarbonate Bottle Use and Urinary Bisphenol A ConcentrationsEnvironmental Health Perspectives, 2009
- Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndromeMolecular and Cellular Endocrinology, 2009
- Bisphenol A at Environmentally Relevant Doses Inhibits Adiponectin Release from Human Adipose Tissue Explants and AdipocytesEnvironmental Health Perspectives, 2008
- Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999–2002Environmental Health, 2008
- Adipokines and the Peripheral and Neural Control of Energy BalanceMolecular Endocrinology, 2008